Ralliant (NYSE:RAL – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.68 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.05, FiscalAI reports. The company had revenue of $567.80 million during the quarter. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. Ralliant updated its FY 2026 guidance to 2.760-2.900 EPS and its Q3 2026 guidance to 0.720-0.780 EPS.
Here are the key takeaways from Ralliant’s conference call:
- Q2 results exceeded guidance, with revenue up 13% year over year to $568 million, adjusted EBITDA margin expanding 390 basis points to 19.8%, and adjusted EPS rising 58% to $0.68. Both segments delivered double-digit organic growth.
- Management raised full-year 2026 guidance to revenue of $2.25 billion–$2.30 billion, adjusted EBITDA margins of 20%–21%, and adjusted EPS of $2.76–$2.90; Q3 revenue is expected at $570 million–$590 million with EPS of $0.72–$0.78.
- Demand remains strong in defense, electrification, utilities, and Test & Measurement, supported by book-to-bill above 1.1 in both segments and defense backlog exceeding $1 billion. The company is expanding manufacturing capacity, including for priority missile programs and utility sensors.
- The Enterprise Productivity Program generated $3 million of savings in Q2 and remains on track for $10 million–$12 million of in-year 2026 savings and $50 million–$60 million of annualized savings by 2028. Free cash flow was $99 million in Q2, while the company returned $161 million to shareholders in the first half.
- Management noted limited visibility in short-cycle Test & Measurement markets and expects growth to moderate after the current recovery year. Semiconductor results will also face a larger year-over-year headwind in Q3 from lapping a major 2025 customer project, while corporate costs are expected to rise to $20 million–$23 million per quarter in the second half.
Ralliant Trading Down 0.0%
RAL traded down $0.01 during mid-day trading on Thursday, reaching $66.96. The stock had a trading volume of 4,483,287 shares, compared to its average volume of 1,709,462. The stock has a market capitalization of $7.49 billion and a P/E ratio of -6.12. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61. The firm’s fifty day simple moving average is $66.98 and its two-hundred day simple moving average is $54.16. Ralliant has a 52 week low of $37.27 and a 52 week high of $75.41.
Ralliant Announces Dividend
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on RAL shares. Royal Bank Of Canada lifted their price objective on Ralliant from $64.00 to $71.00 and gave the company a “sector perform” rating in a research report on Thursday, July 16th. TD Cowen raised their target price on Ralliant from $55.00 to $70.00 and gave the company a “buy” rating in a research note on Wednesday, May 20th. Zacks Research raised Ralliant from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Truist Financial reiterated a “buy” rating and set a $68.00 price target (up from $53.00) on shares of Ralliant in a research report on Wednesday, May 13th. Finally, Vertical Research downgraded shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a research report on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $73.00.
Get Our Latest Stock Report on Ralliant
Key Stories Impacting Ralliant
Here are the key news stories impacting Ralliant this week:
- Positive Sentiment: Q2 earnings and revenue exceeded expectations. Ralliant reported adjusted EPS of $0.68, above the $0.63 consensus and slightly ahead of $0.67 a year earlier. Revenue reached approximately $568 million, up 13% year over year and ahead of estimates. Ralliant Q2 Earnings and Revenues Beat Estimates
- Positive Sentiment: Management raised its outlook. Third-quarter guidance calls for adjusted EPS of $0.72-$0.78 and revenue of $570 million-$590 million, above analyst estimates of $0.68 and $556.4 million, respectively. Full-year adjusted EPS guidance increased to $2.76-$2.90 from a consensus estimate of $2.65, while full-year revenue guidance of roughly $2.3 billion also exceeds expectations. Ralliant Reports Second Quarter 2026 Results and Raises Full Year Guidance
- Positive Sentiment: Profitability improved. Net earnings were $57 million, adjusted net earnings were $76 million, and the reported net earnings margin improved by 60 basis points year over year to 10.1%. Ralliant 2026 Q2 Results Earnings Call Presentation
- Neutral Sentiment: Trading in RAL was briefly halted under a Limit Up-Limit Down pause, indicating heightened volatility but not necessarily a change in the company’s fundamentals.
- Negative Sentiment: The market’s lower reaction indicates that the earnings beat and upgraded guidance may already have been anticipated, or that investors are weighing other details from the results against the stock’s recent gains.
Institutional Investors Weigh In On Ralliant
Institutional investors and hedge funds have recently made changes to their positions in the company. Viking Global Investors LP bought a new position in Ralliant in the second quarter valued at about $257,200,000. State Street Corp bought a new stake in Ralliant during the 2nd quarter worth about $213,096,000. Millennium Management LLC raised its holdings in Ralliant by 172.4% during the 4th quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock worth $253,175,000 after purchasing an additional 3,147,660 shares during the last quarter. Norges Bank acquired a new position in Ralliant during the 4th quarter valued at about $124,687,000. Finally, Invesco Ltd. lifted its position in Ralliant by 90.1% during the 3rd quarter. Invesco Ltd. now owns 3,871,690 shares of the company’s stock valued at $169,309,000 after purchasing an additional 1,835,128 shares during the period.
Ralliant Company Profile
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
See Also
- Five stocks we like better than Ralliant
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
